Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline
should not be considered exclusive of other methods of care reasonably directed at obtaining the
same results. e ultimate judgment concerning the propriety of any course of conduct must be
made by the clinician aer consideration of each individual patient situation. Neither IGC,
the medical associations, nor the authors endorse any product or service associated with the
distributor of this clinical reference tool.
Source
Haugen BR, Alexander EK, Bible KC et al. 2015 American yroid Association
Management Guidelines for Adult Patients with yroid Nodules and Differentiated
yroid Cancer. yroid 2016;26(1):1-133.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2015 All rights reserved
ATADTCTHY15122
Abbreviations
18
FDG-PET, fludeoxyglucose-positron emission tomography; ATA, American yroid
Association; AUS/FLUS, atypia of undetermined significance/follicular lesion of
undetermined significance; FNA, fine needle aspiration; LN, lymph node; PTC, papillary
thyroid cancer; SFN, suspicious for Follicular Neoplasm; SUSP, suspicious for papillary
carcinoma; TSH, thyroid stimulating hormone; US, ultrasound
American yroid Association, Inc.
6066 Leesburg Pike, Suite 550 • Falls Church, Virginia 22041
Phone: 703.998.8890 • Fax: 703.998.8893 • www.thyroid.org
Physician referral, patient resources available online in English and Spanish.
